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Abstract
Background: The effects of ovarian drilling on the serum levels of gonadotropins and androgens
have been studied previously. The aim of this study is to evaluate the effects of ovarian drilling on
the serum prolactin levels and its relation to ovulation in women with polycystic ovary syndrome.
Methods: This is a prospective controlled study. Thirty-six women with PCOS underwent ovarian
electrocauterization in university hospitals. Control group consisted of 35 ovulatory women with
unexplained infertility. Hormonal assessment performed in early follicular phase of spontaneous or
induced cycle before operation in the two groups and repeated one week after operation.
Hormonal assay was also performed in the early follicular phase of the first post-operative
menstruation, folliculometry and progesterone assay were also performed in the same cycle. Data
were analyzed by "repeated measurement design, discriminant analysis, correlation coefficient, and
Fisher exact test".
Results: Six to ten weeks after operation the serum mean +/- SD prolactin levels increased from
284.41 +/- 114.32 mIU/ml to 354.06 +/- 204.42 mIU/ml (P = 0.011). The same values for the control
group were 277.73 +/- 114.65 to 277.4 +/- 111.4 (P = 0.981) respectively. Approximately 45% of
subjects in PCOS group remained anovulatory in spite of decreased level of LH and testosterone.
Prolactin level remained elevated in 73.2% of women who did not ovulate 6–10 weeks after the
procedure.
Conclusion: Hyperprolactinemia after ovarian cauterization may be considered as a possible
cause of anovulation in women with polycystic ovaries and improved gonadotropin and androgen
levels. The cause of hyperprolactinemia is unknown. Hormonal assay particularly PRL in
anovulatory patients after ovarian cauterization is recommended.
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Background
The polycystic ovary syndrome (PCOS) is associated with
chronic anovulation and infertility. In most cases ovula-
tion can be induced with clomiphene citrate (CC) but
approximately 25% of patients fail to ovulate and require
alternative treatment [1]. Human menopausal gonadotro-
pins have been used but the risk of hyperstimulation and
multifetal gestation [2]. A variety of surgical options for
the treatment of PCOS have been applied during laparos-
copy (biopsy, cauterization, laser surgery)[3]. Laparo-
scopic ovarian drilling (LOD) was first described by
Gjonnaess [4]. The reported ovulation rate after LOD var-
ies between 50% and 90% [4-7], the conception rate dose
not increase in parallel with the increase in ovulation rate.
There is also some disparity between hormonal improve-
ment and ovulation rate [7-9]. Part of disparity may be
due to post-operative adhesion formation [10], post-LOD
hyperprolactinemia [11], and any unknown reason.
Although many studies concerning the endocrine effects
of LOD have been performed [12-16], none has empha-
sized on the cause of disparity between hormonal changes
and ovulation. We performed this prospective, controlled
study to evaluate the effects of LOD on hormonal profile
particularly prolactin and their possible effects on
ovulation.
Materials and methods
This study was performed in the Division of Infertility and
Gynecologic Endocrinology, Shiraz University of Medical
Sciences, Shiraz Iran. Between January 1998 and Novem-
ber 2003, 102 women with PCOD were recruited but 60
of them were not eligible and excluded. Thus 42 clomi-
phene-citrate resistant anovulatory women with PCOS
were enrolled into this prospective, controlled study.
Before laparoscopic ovarian drilling, these women had
failed to ovulate with the maximum dose of CC (200 mg/
day for 5 days for at least 5 cycles). Polycystic ovary syn-
drome was diagnosed on the basis of the following crite-
ria: hirsutism, menstrual disturbances (oligo- or
amenorrhea), increased plasma circulating androgens,
LH/FSH ratio>2.5, and typical ultrasonographic findings
[17]. We excluded all women with PRL level >500 MIU/
ml.
The control series consisted of thirty-five unexplained
infertility that had ovulatory cycles and had been referred
for diagnostic laparoscopy. At a minimum, the diagnosis
of unexplained infertility implies a normal semenanaly-
sis, objective evidence of ovulation, a normal uterine cav-
ity, bilateral tubal patency, and normal post-coital test.
They were chosen because the diagnostic laparoscopy pro-
cedure utilized was very similar to the LOD in terms of
premedication and anesthesia. Ethic committee for
Human Research of the university approved the study and
informed consent was taken from each patient. In all
patients baseline blood samples were obtained before
operation (2–3 days after the commencement of sponta-
neous or progesterone induced menstrual bleeding) to
assess serum levels of LH, FSH, PRL, DHEAS and T. First
post-operative blood sample was taken 24 hours after
operation. Second sampling was performed one week
after LOD, and the third blood sample obtained in the
early follicular phase of first post-operative menstrual
cycle (approximately 6–10 weeks after operation). If men-
struation did not occur till one month after LOD, 100 mg
of progesterone would be administered intramuscularly
to stimulate menstruation. This cycle was monitored for
ovulation using serum progesterone (P) measurement in
the mid-luteal phase and folliculometry that was per-
formed on days 14–16 of the first menstrual cycle after
operation. The samples were labeled; serum was separated
and frozen until the end of study when all of them were
assayed by the same kit of radioimmunoassay (RIA). PRL
was measured in plasma pool (3 samples separated by 30
minute intervals). Women with PCOS (Group A) were
treated with laparoscopic ovarian drilling. Laparoscopic
ovarian drilling was performed using two-puncture tech-
nique. We used an optic that equipped with operative
channel. The laparoscope was introduced through a sub-
umblical incision and a grasping forceps was introduced
suprapubically to stabilize the ovary by grasping the ovar-
ian ligament. After assessment of the pelvic structures and
tubal patency, an insulated needle connected to a unipo-
lar electrocautery unit was inserted through operative
channel of the optic. Eight to ten cautery points 3–4 mm
in diameter was created in each ovary with a current of 4
mA applied through the laparoscopic insulated needle.
Control group (Group B) underwent diagnostic laparos-
copy as standard double puncture method under general
anesthesia by the same surgeons and anesthetists.
Statistical methods
Pre-operative and post-operative clinical and endocrino-
logic parameters in various sessions were compared using
"repeated measurement design (Bonferroni test"). Fisher
exact test was used to determine progesterone changes
and menstruation in the two groups after procedure. We
also used "discriminant analysis" for ovulation as depend-
ent factor and other study parameters. Correlation of pro-
lactin levels with ovulation was compared using
"correlation coefficient test".
Normal values of hormonal levels
FSH = 3–13 mIU/ml, LH = 1.5–12 mIU/ml, Testosterone
= 0.2–0.9 ng/ml, DHEAS = 80–350 microgram/dl, Prolac-
tin= 50–450 mIU/ml.
Results
Of a total of forty-two PCOS women enrolled, 36 com-
pleted the study protocol, 6 lost to follow up and wereReproductive Biology and Endocrinology 2005, 3:31 http://www.rbej.com/content/3/1/31
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excluded. We also excluded five women in control group
who did not complete the measurements. Ultimately, 36
women in PCOS group and 30 women in control group
underwent final analysis. Mean age in PCOS and control
groups were 24.11 +/- 3.22(range 19 to 31) and 24.5 +/-
3.95(range 19 to 32) respectively. Typical endocrine pro-
files of baseline, and after operation (24 hours, one week
and 6–10 weeks) of the two groups are shown in (Table
1). After operation, PRL levels in the both groups
increased significantly at 24 hours (P < 0.001) while the
other hormonal profiles showed no such changes. Serum
levels of LH (P < 0.001), T (P < 0.001), and also LH/FSH
ratio (P < 0.001) decreased to a statistically significant
level 6–10 weeks after operation. Comparison of study
parameters in PCOS group: women who ovulated sponta-
neously Vs. women who did not ovulated spontaneously,
showed that prolactin levels were significantly higher in
anovulatory group and follicle size (F.Size) is grater in
ovulatory group (Table 2). Hormonal profiles at baseline
and all sessions after operation between PCOS and con-
trol group were compared. The results are depicted in
Table 3. Twenty-four hours after operation serum PRL lev-
Table 1: Hormonal profile(Mean +/-SD) at baseline and various sessions after operation in PCOS and control group (All post operative 
sessions compared with baseline).
0 1(P.Value) 2(P.Value) 3(P.Value)
1-FSH
PCOS 6.4+/-1.97 6.21+/-1.71(0.904) 6.35+/-1.68(0.616) 6.17+/-1.62(0.812)
Control 6.74+/-1.75 6.81+/-1.39(0.782) 6.58+/-1.79(0.417) 6.47+/-1.24(0.407)
2-LH
PCOS 16.21+/-4.41 14.28+/-4.04(0.001)* 13.95+/-3.54(0.001)* 8.26+/-2.17(0.001)*
Control 8.02+/-1.31 8.32+/-1.68(0.356) 8.31+/-1.98(0.403) 7.78+/-1.49(0.470)
3-LH/FSH R
PCOS 2.71+/-0.58 2.36+/-0.59(0.002)* 2.3+/-0.7(0.001)* 1.42+/-0.47(0.001)*
Control 1.23+/-0.22 1.23+/-0.13(0.961) 1.28+/-0.13(0.295) 1.22+/-0.23(0.897)
4-DHEA, S
PCOS 201.14+/-103.21 199.5+/-98.92(0.772) 195.17+/-9043(0.538) 199.56+/-95.1(0.794)
Control 198.37+/-82.66 186.77+/-73.75(0.262) 187.2+/-79.97(0.157) 191.17+/-68.04(0.306)
5-T
PCOS 1.18+/-0.33 1.12+/-0.31(0.008)* 1.08+/-0.28(0.001)* 0.78+/-0.25(0.001)*
Control 0.66+/-0.23 0.54+/-0.22(0.004)* 0.61+/-0.17(0.095) 0.62+/-0.17(0.081)
6-PRL
PCOS 284.41+/-114.32 651.83+/-316.79(0.001)* 530.31+/-206.74(0.001)* 354.06+/-204.42(0.011)*
Control 277.73+/-114.65 732.23+/-209.91(0.001)* 512.7+/-131.1(0.001)* 277.4+/-111.4(0.981)
7-Prog
PCOS - - - 5.99+/-3.68
Control - - - 8.58+/-2.31
0 = Baseline
1 = Mean+/-SD 24 h after operation
2 = Mean+/-SD one week after operation
3 = Mean+/-SD 6–10 weeks after operation
*= significant P value (P < 0.05)
Table 2: Comparison of study parameters in PCOS group. Women who ovulated spontaneously Vs. women who did nor ovulated 
spontaneously.
Anovulatory group Ovulatory group P value
1-Age 24.31 +/- 3.6 23.95 +/-2.92 0.74
2-FSH 5.91+/-1.95 6.37 +/-1.31 0.4
3-LH 8.06 +/-1.99 8.42 +/-2.33 0.63
4-DHEAS 209.125+/-96.033 191.9 +/-96.13 0.59
5-T 0.75 +/-0.26 0.8 +/-0.24 0.52
6-PRL 501.31 +/-205.130 236.25 +/-104.34 0.000*
7-F. Size 9.45 +/-1.48 17.1 +/-1.33 0.000*Reproductive Biology and Endocrinology 2005, 3:31 http://www.rbej.com/content/3/1/31
Page 4 of 6
(page number not for citation purposes)
els rose in 88.9% of PCOS and 100% of control group
respectively (Table 1). Serum PRL levels remained ele-
vated 6–10 weeks after operation in 27.8% of PCOS (P <
0.05) and 6.7% of control group (P > 0.05)(Table 4). After
operation, 20(55.6%) of PCOS and 30 (100%) of control
group ovulated as indicated by midluteal serum progester-
one level > 5 ng/ml, spontaneous menstruation and lead-
ing follicular size >15 mm (Table 4). Of all patients that
remained anovulatory in spite of decrease in LH and T
after LEC, PRL remained higher than normal limits in
62.5%.
Discussion
This is the first prospective, controlled study on the PRL
level after LOD Vs. diagnostic laparoscopy. Our study
shows that laparoscopic ovarian drilling can restore ovu-
lation in some but not all PCOS women. This confirms
the results from previous studies [4-7]. Kovacs et al [12] in
their recent study of comparison of ovulation and preg-
nancy rate has found no difference in success rates
between ovarian drilling and gonadotropin ovulation
induction for such women in spite of hormonal improve-
ment after LOD. Abdel Ghadir et al [7] also reported that
beside its favorable endocrine effects, ovarian drilling
revealed the same rate of ovulation and pregnancy in
comparison with HMG induced cycle. In the present study
we were able to show that with ovarian drilling, T and LH
levels decreased irrespective of ovulation. LH and T
decreased in 75% and 70% of PCOS patients respectively,
whereas only 52.8% of women who underwent ovarian
drilling ovulated. Periovarian adhesion after ovarian elec-
trocautery seems to be the main cause of disparity
Table 3: Comparison hormonal profiles(Mean+/-SD) at baseline and various sessions after operation, between PCOS & control group.
0 (P value) 1(p value) 2 (p value) 3 (p value)
1-FSH
PCOS 6.4+/-1.97 (0.27) 6.21+/-1.71(0.131) 6.35+/-1.68(0.555) 6.17+/-1.62(0.31)
Control 6.74+/-1.75 6.81+/-1.39 6.58+/-1.79 6.47+/-1.24
2-LH
PCOS 16.21 +/-4.41(<0.001)* 14.28+/-4.04(<0.001) * 13.95+/-3.54(<0.001) * 8.26+/-2.17(0.24)
Control 8.02+/-1.31 8.32+/-1.68 8.31+/-1.98 7.78+/-1.49
3-DHEAS
PCOS 201.14 +/-103.2(0.906) 199.5+/-98.92(0.562) 195.17+/-90.43(0.699) 199.56+/-95.1(0.029)
Control 198.37+/-82.66 186.77+/-73.75 187.2+/-79.97 191.17+/-68.04
4-T
PCOS 1.18 +/-0.33(0.001) * 1.12+/-0.31(<0.001) * 1.08+/-0.28(<0.001) * 0.78+/-0.25(0.1)
Control 0.66 +/-0.23 0.54+/-0.22 0.61+/-0.17 0.62+/-0.17
5-PRL
PCOS 284.41+/-114.32(0.814) 651.83+/-316.76(0.239) 530.31+/-206.74(0.688) 354.06+/-204.42(0.006)*
Control 277.73+/-114.65 732.23+/-209.9 512.7+/-131.1 277.4+/-111.4
0 = Baseline 1
= Mean+/-SD 24 h after operation
2 = Mean+/-SD one week after operation
3 = Mean+/-SD 6-10 weeks after operation * = significant P value (P < 0.05)
Table 4: Clinical and hormonal outcome 6–10 weeks after operation in the two groups.
NOPW L.F>15 mm (%) NOPW Prog>5 ng/ml
(%)
NOPW S.M (%) NOPW E. PRL (%)
1-PCOS 19(52.8) 20(55.6)* 20(55.6)* 10(27.8)*
2-Control 21(70) 30(100) 30(100) 2.(6.7%)
* = significant P Value
Differences compared with pre-operation value
NOPW L.F = Number of Patients With Leading Follicle.
NOPW Prog = Number of Patients With Progesterone
NOWP S.M = Number of Patients With Spontaneous Menstruation.
NOPW E. PRL = Number of Patients With Elevated Prolactin.Reproductive Biology and Endocrinology 2005, 3:31 http://www.rbej.com/content/3/1/31
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between ovulation and pregnancy rate. Many authors
believe that although periovarian adhesion after ovarian
drilling is much less when compared with ovarian wedge
resection, still some significant adnexal adhesion that
adversely affects fertility may be considered [10,18,19].
The unanswered question concerning the effects of ovar-
ian drilling is the disparity between favorable endocrine
effects of this procedure and ovulation rate. Concerning
the endocrine effects of LOD, Gjonness et al [20] in their
study on 17 women showed a transient hyperprolactine-
mia immediately after LOD. They believed that this phe-
nomenon was due to operative stress. Eldib et al in their
unpublished study on 20 women with PCOS showed that
LOD was associated with increased PRL levels by 7 folds
two weeks after operation.
We hypothesized that the disparity seen between hormo-
nal improvement and ovulation rate might be due to the
hyperprolactinemia associated LOD. Of all operated
women that remained anovulatory in spite of significant
fall in LH and T levels, PRL remained elevated in 62.5%
when measured 6–10 weeks after operation. Serum prol-
actin level began to rise from the first day after LOD in the
two groups. Six to ten weeks after operation, PRL level in
the women with PCOS was significantly higher than con-
trol group. Hyperprolactinemia as a complication of oper-
ation, and/or anesthesia was previously described by
Adashi [21], Chan [22], Frantz [23], Newsome [24], Char-
ters [25], and Soules et al [26]. An elevated PRL level was
common finding during and after operation with the peak
PRL levels always occurring during surgery. The elevated
post-operative PRL levels may be explained by a general-
ized stress reaction (e.g., pain) and by medications known
to stimulate PRL release (e.g., narcotics) [27]. We did not
measure PRL intra-operatively, but post-operative ele-
vated levels of PRL support the results of previous studies.
Noel et al [28] and Sowers [29] reported an acute increase
in PRL concentration with the induction of anesthesia
prior to the operative incision. The operative increase in
PRL was greater in women than in men and persisted for
a various periods [28]. The post-operative elevated PRL
levels improved spontaneously after a maximum period
of one week. Approximately all subjects in the two groups
and the most cases of PCOS had normal PRL 6–10 weeks
after LOD. A large number of women with PCOS, who
remained anovulatory after LOD, had still elevated serum
PRL levels. Gjonnaess in his study of long term follow up
showed no difference between baseline PRL levels and
PRL levels after 3 months or later after LOD [30]. The dis-
parity between this study and our results may be due to
the longer duration between LOD and PRL assay in Gjon-
naess group. Since the LOD and control group were in the
same condition concerning the surgical and anesthesio-
logic stress, and the post-operation elevated PRL level was
supposed to decrease after one week, the elevated PRL lev-
els 6–10 weeks after operation in LOD group may be due
to other cause than surgical or anesthesiologic stress. The
mechanism for the increase in PRL levels after LOD
remains speculative. The possible mechanism might be
scar formation on the surface of ovaries and chronic stim-
ulation of ovarian nerves and causing neurogenic hyper-
prolactinemia, like chest wall lesion, intercourse or spinal
cord lesions. For documentation of this hypothesis ani-
mal models should be designed.
In this prospective controlled study control group helped
us to differentiate stress-induced hyperprolactinemia
from the hyperprolactinemia associated with LOD. The
weak point of this preliminary report is that the hormonal
assay was performed in early and late post-operative
phase. More exact hormonal study is necessary to evaluate
the condition. However this study provides a potential
new way to evaluate the factors that affecting ovulation
rate after LOD including hyperprolactinemia. It seems
that animal study to evaluate the relationship between
ovarian damage and PRL levels would be helpful. Increase
in serum PRL levels associated with LOD has several
implications in clinical practice; 1- post-operative
elevated PRL levels affects gonadotropins and ovarian
steroidogenesis [31,32], so it would be prudent not to rely
on early hormonal profiles after LOD, 2- Since the latent
hyperprolactinemia may lead to luteal phase defect [33] if
the first cycle after LOD was ovulatory, luteal phase defect
must be considered and treated. 3- If ovulation did not
occurred as expected, diagnosis and treatment of hyper-
prolactinemia should be undertaken.
Conclusion
We conclude that after ovarian drilling, women who
remained anovulatory in spite of decreased serum andro-
gen levels and other hormonal profile improvement, may
have elevated prolactin levels. The cause of hyperprol-
actinemia in these patients has not known. Hormonal
assay particularly PRL in anovulatory patients after LOD is
recommended. Animal study to evaluate the relationship
between ovarian damage and PRL levels would be helpful
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